CEJEMLY
Concentrate for solution for infusion, 600mg
RxActive license
Active substance (INN)
sugemalimab
Pharmaceutical form
Pharmaceutical formConcentrate for solution for infusion
Strength600mg
PackagingUkupno 2 bočice staklene sa po 20ml koncentrata za rastvor za infuziju u kartonskoj kutiji
ManufacturerManufacturing Packaging Farmaca (MPF) B.V., Netherlands
Therapeutic groupAntineoplastic and immunomodulating agents (L01FF11)
Marketing authorization holder"EVROPA LEK PHARMA" DOO PODGORICA
Authorization dateAugust 13, 2025
Source: CInMED register